Dexcom (DXCM) stock: analyst price target and their real reliability
Live quote · data updated Oct 14, 2026
Dexcom · Health Care · ref. ETF XLV · 83 calls · price $85.06
What the company does: DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems for the management of diabetes and metabolic health in the United States and internationally.
📈 Dexcom (DXCM) stock price
$85.06+28.5% over range
Oct 14, 25low $54.84 · high $92.34Oct 13, 26
📏 Click 2 points (left → right) to measure the change · click again to clear.
SellBuy
Buy
94% recommend buying · 16 analysts
📊 JPI status : Dexcom has never appeared in a JPI ranking (Fair or Risk +) — our methods haven't picked it to date. See the selected stocks →
🎯 DXCM price target & analyst consensus — price $85.06
The price target · all analysts combined (16 targets)
Highest target · 1 firm of 16$115+35.2%
Median target · of 16 targets$95+11.7%
Lowest target · 1 firm of 16$80-5.9%
Current price$85.06
Where these 16 targets sit · versus the current price · 1 target per firm, last 6 months
Above the price
1381%
$86 ↔ $115
Below
319%
$80 ↔ $82
⭐ What the most reliable analysts say
· those who beat their sector, targets replayed on real prices
⭐ The most reliable of them, either direction: JP Morgan — 68% of its targets hit on this sector (364 calls tested). It aims for $82 (-3.6 %), call made on August 1, 2026, maturing on August 1, 2027 (74 d ago).
The 13 reliable analysts
$95+12 %
The 3 other firms
$86+1.1 %
How to read it: the 13 reliable firms are not filtered by optimism — 11 aim above the price, 2 below, hence their $95 median. “The 3 others” are the firms that don't pass our reliability filter on this sector.
The consensus · 16 ratings (last 6 months)
Strong Buy00%
Buy1594%
Hold16%
Sell00%
Strong Sell00%
Go deeper on the analysts
🎯 DXCM price target all
All 18 calls, one by one, with our verdict on each firm.
→ See all 18 targets, analyst by analyst💡 The best analysts on DXCM most reliable
The case for and against, with the numbers, per those who've been right on the stock.
→ Should you invest in DXCM? The case for & againstAll analysts (the consensus) · vs · the best (those who've been right)
💬 A question about Dexcom? The JPI assistant answers using our backtest data.
📈 Dexcom fundamentals: valuation, margins & growth › open the full page
P/E 33.8Net margin 20.1 %Revenue growth +13.1 %Cheap for the growth
Revenue, net income and margin per year
Revenue Net income · hover a bar for details
2022
marg. 12 %
2023
Rev +24%Profit +59%
2024
Rev +11%Profit +6%
2025
Rev +16%Profit +45%
🔎 Detailed analyses
🏛️ Which US Congress members hold Dexcom (DXCM)?
2 Congress members have disclosed DXCM buys. Click a highlighted name to see their track record (do they beat the S&P 500?).
Thomas Suozzi 2× · 38%Kevin Hern 1× · 48%
✅ Historical analyst reliability on DXCM
Hit rate measured on targets already matured (12 months), replayed against real prices. Click a header to sort.
| Firm ↕ | % right i ↕ | Gain vs sector i ↕ | Calls i ↕ |
|---|---|---|---|
| Wunderlich Securities | 100% | +120.6% | 3 |
| BMO Capital ↗ | 100% | +96.7% | 5 |
| Cowen & Co. | 100% | +76.5% | 3 |
| Wedbush ↗ | 100% | +73.7% | 2 |
| B of A Securities ↗ | 100% | +59.1% | 6 |
| Benchmark ↗ | 100% | +47.0% | 2 |
| Stephens & Co. ↗ | 100% | +38.4% | 3 |
| JP Morgan ↗ | 92% | +53.0% | 12 |
| Jefferies ↗ | 88% | +52.8% | 8 |
| Stifel ↗ | 73% | +32.0% | 11 |
See the other 19 firms
| Feltl & Co. | 0% | -59.1% | 2 |
| Leerink Partners ↗ | 0% | -8.5% | 2 |
| Mizuho ↗ | 0% | -6.1% | 2 |
| Wells Fargo ↗ | 14% | -12.2% | 7 |
| RBC Capital ↗ | 25% | -3.0% | 4 |
| Northland Capital Markets ↗ | 33% | -34.5% | 3 |
| Goldman Sachs ↗ | 33% | -15.4% | 3 |
| SVB Leerink | 50% | -8.7% | 4 |
| Guggenheim ↗ | 50% | +4.3% | 2 |
| Bernstein ↗ | 50% | +35.8% | 2 |
| Sterne Agee | 50% | +42.6% | 2 |
| Baird ↗ | 55% | +40.3% | 11 |
| Citigroup ↗ | 58% | +0.3% | 12 |
| Piper Sandler ↗ | 59% | +5.3% | 17 |
| UBS ↗ | 60% | -5.9% | 5 |
| Oppenheimer ↗ | 62% | +10.2% | 8 |
| Raymond James ↗ | 63% | +24.4% | 30 |
| BTIG ↗ | 67% | +7.0% | 9 |
| Canaccord Genuity ↗ | 71% | +36.0% | 24 |
📊 What $1,000 invested in Dexcom would be worth › open the full page
In short — $1,000 invested in Dexcom 10 years ago would be worth $3,289 today, i.e. +13%/yr on average. Best year: 2018 (+109%), worst: 2024 (-37%). Price performance, excluding dividends.
If I'd invested $1,000 in Dexcom
| Investment | Worth today | Gain |
|---|---|---|
| 1 years ago | $866 | -13% |
| 3 years ago | $595 | -41% |
| 5 years ago | $729 | -27% |
Return by year (Dexcom)
| Year | Return | $1,000 invested at year start |
|---|---|---|
| 2026 (YTD) | +1% | $1,015 (+1%) |
| 2025 | -15% | $866 (-13%) |
| 2024 | -37% | $543 (-46%) |
⚠️ Past performance, not predictive nor advice. Prices in $, excluding dividends. Yahoo Finance data.
📰 Recent news on Dexcom
Loading news…
📋 All analyst calls on DXCM
Filtered on — · ✕ show all
▲ Buy · 🎯$96
Price at call : $85.92 — upside +12%
Today : $85.06 — upside +13%
🎯 on DXCM : 67% (9 calls matureds) · 📊 on Health : 51.2% · +5.3% (123 calls)
in progress (365j)
matures : Oct 12, 27
matures : Oct 12, 27
▲ Overweight · 🎯$115
Price at call : $84.3 — upside +36%
Today : $85.06 — upside +35%
🎯 on DXCM : no call matured yet · 📊 on Health : 50.1% · +2.0% (645 calls)
in progress (365j)
matures : Oct 7, 27
matures : Oct 7, 27
RBC Capital ↗
Oct 1, 26
▲ Outperform · 🎯$105
Price at call : $86.23 — upside +22%
Today : $85.06 — upside +23%
🎯 on DXCM : no call matured yet · 📊 on Health : 42.8% · -2.5% (397 calls)
in progress (365j)
matures : Oct 1, 27
matures : Oct 1, 27
Truist Securities ↗
Sep 18, 26
▲ Buy · 🎯$102
Price at call : $89.17 — upside +14%
Today : $85.06 — upside +20%
🎯 on DXCM : no call matured yet · 📊 on Health : 49.4% · +2.3% (263 calls)
in progress (365j)
matures : Sep 18, 27
matures : Sep 18, 27
▲ Buy · 🎯$95
Price at call : $89.17 — upside +7%
Today : $85.06 — upside +12%
🎯 on DXCM : no call matured yet · 📊 on Health : 48% · +0.6% (98 calls)
in progress (365j)
matures : Sep 18, 27
matures : Sep 18, 27
Argus Research ↗
Aug 4, 26
▲ Buy · 🎯$96
Price at call : $82.66 — upside +16%
Today : $85.06 — upside +13%
🎯 on DXCM : no call matured yet · 📊 on Health : 55.3% · +2.1% (159 calls)
in progress (365j)
matures : Aug 4, 27
matures : Aug 4, 27
Canaccord Genuity ↗
Aug 3, 26
▲ Buy · 🎯$90
Price at call : $86.94 — upside +4%
Today : $85.06 — upside +6%
🎯 on DXCM : 42% (12 calls matureds) · 📊 on Health : 52.6% · +5.0% (154 calls)
in progress (365j)
matures : Aug 3, 27
matures : Aug 3, 27
▲ Buy · 🎯$88
Price at call : $87.31 — upside +1%
Today : $85.06 — upside +3%
🎯 on DXCM : no call matured yet · 📊 on Health : 53.1% · +2.4% (516 calls)
in progress (365j)
matures : Jul 31, 27
matures : Jul 31, 27
See the other 75 calls, newest to oldest
RBC Capital ↗
Jul 31, 26
▲ Outperform · 🎯$90
Price at call : $87.31 — upside +3%
Today : $85.06 — upside +6%
🎯 on DXCM : no call matured yet · 📊 on Health : 42.8% · -2.5% (397 calls)
in progress (365j)
matures : Jul 31, 27
matures : Jul 31, 27
▲ Outperform · 🎯$95
Price at call : $87.31 — upside +9%
Today : $85.06 — upside +12%
🎯 on DXCM : no call matured yet · 📊 on Health : 51.4% · +3.4% (222 calls)
in progress (365j)
matures : Jul 31, 27
matures : Jul 31, 27
■ Neutral neutral · not a buy · 🎯$82
Price at call : $87.31 — gap to target -6%
Today : $85.06 — gap to target -4%
🎯 on DXCM : no call matured yet · 📊 on Health : 53.8% · +5.2% (364 calls)
in progress (365j)
matures : Jul 31, 27
matures : Jul 31, 27
Piper Sandler ↗
Jul 31, 26
▲ Overweight · 🎯$95
Price at call : $87.31 — upside +9%
Today : $85.06 — upside +12%
🎯 on DXCM : no call matured yet · 📊 on Health : 46.6% · -1.4% (324 calls)
in progress (365j)
matures : Jul 31, 27
matures : Jul 31, 27
Wells Fargo ↗
Jul 31, 26
▲ Overweight · 🎯$90
Price at call : $87.31 — upside +3%
Today : $85.06 — upside +6%
🎯 on DXCM : no call matured yet · 📊 on Health : 47.6% · +1.0% (403 calls)
in progress (365j)
matures : Jul 31, 27
matures : Jul 31, 27
▲ Buy · 🎯$95
Price at call : $87.31 — upside +9%
Today : $85.06 — upside +12%
🎯 on DXCM : no call matured yet · 📊 on Health : 50.7% · +7.8% (304 calls)
in progress (365j)
matures : Jul 31, 27
matures : Jul 31, 27
▲ Buy · 🎯$82
Price at call : $83.45 — upside -2%
Today : $85.06 — upside -4%
🎯 on DXCM : no call matured yet · 📊 on Health : 45% · -3.6% (20 calls)
in progress (365j)
matures : Jul 31, 27
matures : Jul 31, 27
Truist Securities ↗
Jul 31, 26
▲ Buy · 🎯$93
Price at call : $83.45 — upside +11%
Today : $85.06 — upside +9%
🎯 on DXCM : no call matured yet · 📊 on Health : 49.4% · +2.3% (263 calls)
in progress (365j)
matures : Jul 31, 27
matures : Jul 31, 27
▲ Buy · 🎯$90
Price at call : $83.45 — upside +8%
Today : $85.06 — upside +6%
🎯 on DXCM : 67% (9 calls matureds) · 📊 on Health : 51.2% · +5.3% (123 calls)
in progress (365j)
matures : Jul 31, 27
matures : Jul 31, 27
Truist Securities ↗
Jul 16, 26
▲ Buy · 🎯$87
Price at call : $76.65 — upside +14%
Today : $85.06 — upside +2%
🎯 on DXCM : no call matured yet · 📊 on Health : 49.4% · +2.3% (263 calls)
in progress (365j)
matures : Jul 16, 27
matures : Jul 16, 27
▲ Outperform · 🎯$90
Price at call : $77.98 — upside +15%
Today : $85.06 — upside +6%
🎯 on DXCM : no call matured yet · 📊 on Health : 51.4% · +3.4% (222 calls)
in progress (365j)
matures : Jul 15, 27
matures : Jul 15, 27
Deutsche Bank ↗
Jun 23, 26
▲ Buy · 🎯$86
Price at call : $68.92 — upside +25%
Today : $85.06 — upside +1%
🎯 on DXCM : no call matured yet · 📊 on Health : 53.1% · +4.5% (292 calls)
in progress (365j)
matures : Jun 23, 27
matures : Jun 23, 27
Piper Sandler ↗
Jun 15, 26
▲ Overweight · 🎯$88
Price at call : $74.22 — upside +19%
Today : $85.06 — upside +3%
🎯 on DXCM : no call matured yet · 📊 on Health : 46.6% · -1.4% (324 calls)
in progress (365j)
matures : Jun 15, 27
matures : Jun 15, 27
▲ Buy · 🎯$95
Price at call : $75.25 — upside +26%
Today : $85.06 — upside +12%
🎯 on DXCM : no call matured yet · 📊 on Health : 48% · +0.6% (98 calls)
in progress (365j)
matures : Jun 10, 27
matures : Jun 10, 27
▲ Outperform · 🎯$85
Price at call : $78.19 — upside +9%
Today : $85.06 — upside -0%
🎯 on DXCM : no call matured yet · 📊 on Health : 51.4% · +3.4% (222 calls)
in progress (365j)
matures : Jun 9, 27
matures : Jun 9, 27
▲ Buy · 🎯$90
Price at call : $76.62 — upside +17%
Today : $85.06 — upside +6%
🎯 on DXCM : no call matured yet · 📊 on Health : 50.7% · +7.8% (304 calls)
in progress (365j)
matures : Jun 5, 27
matures : Jun 5, 27
▲ Buy · 🎯$84
Price at call : $73.74 — upside +14%
Today : $85.06 — upside -1%
🎯 on DXCM : no call matured yet · 📊 on Health : 53.1% · +2.4% (516 calls)
in progress (365j)
matures : May 28, 27
matures : May 28, 27
Canaccord Genuity ↗
May 18, 26
▲ Buy · 🎯$82
Price at call : $66.95 — upside +22%
Today : $85.06 — upside -4%
🎯 on DXCM : 42% (12 calls matureds) · 📊 on Health : 52.6% · +5.0% (154 calls)
in progress (365j)
matures : May 18, 27
matures : May 18, 27
B of A Securities ↗
May 18, 26
▲ Buy · 🎯$80
Price at call : $66.95 — upside +19%
Today : $85.06 — upside -6%
🎯 on DXCM : no call matured yet · 📊 on Health : 48.1% · +2.0% (362 calls)
in progress (365j)
matures : May 18, 27
matures : May 18, 27
▼ Underweight · 🎯$64
Price at call : $66.95 — upside -4%
Today : $85.06 — upside -25%
🎯 on DXCM : no call matured yet · 📊 on Health : 50.1% · +2.0% (645 calls)
in progress (365j)
matures : May 18, 27
matures : May 18, 27
▲ Buy · 🎯$79
Price at call : $59.48 — upside +33%
Today : $85.06 — upside -7%
🎯 on DXCM : no call matured yet · 📊 on Health : 53.1% · +2.4% (516 calls)
in progress (365j)
matures : May 4, 27
matures : May 4, 27
Canaccord Genuity ↗
May 2, 26
▲ Buy · 🎯$100
Price at call : $60.04 — upside +67%
Today : $85.06 — upside +18%
🎯 on DXCM : 42% (12 calls matureds) · 📊 on Health : 52.6% · +5.0% (154 calls)
in progress (365j)
matures : May 2, 27
matures : May 2, 27
▲ Buy · 🎯$75
Price at call : $60.04 — upside +25%
Today : $85.06 — upside -12%
🎯 on DXCM : no call matured yet · 📊 on Health : 48% · +0.6% (98 calls)
in progress (365j)
matures : May 1, 27
matures : May 1, 27
▼ Underweight · 🎯$67
Price at call : $60.04 — upside +12%
Today : $85.06 — upside -21%
🎯 on DXCM : no call matured yet · 📊 on Health : 50.1% · +2.0% (645 calls)
in progress (365j)
matures : May 1, 27
matures : May 1, 27
▲ Buy · 🎯$84
Price at call : $65.26 — upside +29%
Today : $85.06 — upside -1%
🎯 on DXCM : no call matured yet · 📊 on Health : 53.1% · +2.4% (516 calls)
in progress (365j)
matures : Mar 11, 27
matures : Mar 11, 27
▲ Buy · 🎯$85
Price at call : $68.74 — upside +24%
Today : $85.06 — upside -0%
🎯 on DXCM : 67% (9 calls matureds) · 📊 on Health : 51.2% · +5.3% (123 calls)
in progress (365j)
matures : Mar 9, 27
matures : Mar 9, 27
▲ Buy · 🎯$85
Price at call : $73.16 — upside +16%
Today : $85.06 — upside -0%
🎯 on DXCM : 67% (9 calls matureds) · 📊 on Health : 51.2% · +5.3% (123 calls)
in progress (365j)
matures : Feb 25, 27
matures : Feb 25, 27
Truist Securities ↗
Feb 17, 26
▲ Buy · 🎯$80
Price at call : $72.8 — upside +10%
Today : $85.06 — upside -6%
🎯 on DXCM : no call matured yet · 📊 on Health : 49.4% · +2.3% (263 calls)
in progress (365j)
matures : Feb 17, 27
matures : Feb 17, 27
Canaccord Genuity ↗
Feb 13, 26
▲ Buy · 🎯$95
Price at call : $70.43 — upside +35%
Today : $85.06 — upside +12%
🎯 on DXCM : 42% (12 calls matureds) · 📊 on Health : 52.6% · +5.0% (154 calls)
in progress (365j)
matures : Feb 13, 27
matures : Feb 13, 27
▼ Underweight · 🎯$72
Price at call : $70.43 — upside +2%
Today : $85.06 — upside -15%
🎯 on DXCM : no call matured yet · 📊 on Health : 50.1% · +2.0% (645 calls)
in progress (365j)
matures : Feb 13, 27
matures : Feb 13, 27
Wells Fargo ↗
Feb 13, 26
▲ Overweight · 🎯$85
Price at call : $70.43 — upside +21%
Today : $85.06 — upside -0%
🎯 on DXCM : no call matured yet · 📊 on Health : 47.6% · +1.0% (403 calls)
in progress (365j)
matures : Feb 13, 27
matures : Feb 13, 27
▲ Outperform · 🎯$90
Price at call : $70.02 — upside +29%
Today : $85.06 — upside +6%
🎯 on DXCM : no call matured yet · 📊 on Health : 51.4% · +3.4% (222 calls)
in progress (365j)
matures : Feb 13, 27
matures : Feb 13, 27
▲ Buy · 🎯$85
Price at call : $70.02 — upside +21%
Today : $85.06 — upside -0%
🎯 on DXCM : 67% (9 calls matureds) · 📊 on Health : 51.2% · +5.3% (123 calls)
in progress (365j)
matures : Feb 13, 27
matures : Feb 13, 27
▼ Underweight · 🎯$71
Price at call : $70.25 — upside +1%
Today : $85.06 — upside -17%
🎯 on DXCM : no call matured yet · 📊 on Health : 50.1% · +2.0% (645 calls)
in progress (365j)
matures : Jan 12, 27
matures : Jan 12, 27
▲ Outperform · 🎯$86
Price at call : $70.98 — upside +21%
Today : $85.06 — upside +1%
🎯 on DXCM : no call matured yet · 📊 on Health : 55.7% · +5.7% (70 calls)
in progress (365j)
matures : Jan 9, 27
matures : Jan 9, 27
▲ Outperform · 🎯$78
Price at call : $65.75 — upside +19%
Today : $85.06 — upside -8%
🎯 on DXCM : no call matured yet · 📊 on Health : 51.4% · +3.4% (222 calls)
in progress (365j)
matures : Dec 17, 26
matures : Dec 17, 26
▲ Buy · 🎯$77
Price at call : $66.96 — upside +15%
Today : $85.06 — upside -9%
🎯 on DXCM : no call matured yet · 📊 on Health : 53.1% · +2.4% (516 calls)
in progress (365j)
matures : Dec 11, 26
matures : Dec 11, 26
Morgan Stanley ↗
Dec 2, 25
▲ Overweight · 🎯$75
Price at call : $64.85 — upside +16%
Today : $85.06 — upside -12%
🎯 on DXCM : no call matured yet · 📊 on Health : 51.6% · +5.2% (830 calls)
in progress (365j)
matures : Dec 2, 26
matures : Dec 2, 26
Evercore ISI Group ↗
Nov 25, 25
■ In-Line neutral · not a buy · 🎯$68
Price at call : $61.69 — gap to target +10%
Today : $85.06 — gap to target -20%
🎯 on DXCM : no call matured yet · 📊 on Health : 44.6% · -0.4% (186 calls)
in progress (365j)
matures : Nov 25, 26
matures : Nov 25, 26
Morgan Stanley ↗
Nov 10, 25
■ Equal-Weight neutral · not a buy · 🎯$63
Price at call : $58.13 — gap to target +8%
Today : $85.06 — gap to target -26%
🎯 on DXCM : no call matured yet · 📊 on Health : 51.6% · +5.2% (830 calls)
in progress (365j)
matures : Nov 10, 26
matures : Nov 10, 26
Argus Research ↗
Nov 7, 25
▲ Buy · 🎯$90
Price at call : $54.84 — upside +64%
Today : $85.06 — upside +6%
🎯 on DXCM : no call matured yet · 📊 on Health : 55.3% · +2.1% (159 calls)
in progress (365j)
matures : Nov 7, 26
matures : Nov 7, 26
▲ Buy · 🎯$95
Price at call : $61.18 — upside +55%
Today : $85.06 — upside +12%
🎯 on DXCM : no call matured yet · 📊 on Health : 51.7% · +3.1% (358 calls)
in progress (365j)
matures : Nov 3, 26
matures : Nov 3, 26
Canaccord Genuity ↗
Sep 29, 25
▲ Buy · 🎯$106
Price at call : $67.29 — upside +58%
Today : $85.06 — upside +25%
Expected +58% · Actual +28% · Reason (≥ +15%) : ✓ Yes
🎯 on DXCM : 42% (12 calls matureds) · 📊 on Health : 52.6% · +5.0% (154 calls)
+28.2%
stock +28% · XLV +21%
matured Sep 29, 26
Canaccord Genuity ↗
Aug 1, 25
▲ Buy · 🎯$106
Price at call : $76.25 — upside +39%
Today : $85.06 — upside +25%
Expected +39% · Actual +14% · Reason (≥ +15%) : ✗ No
🎯 on DXCM : 42% (12 calls matureds) · 📊 on Health : 52.6% · +5.0% (154 calls)
+14.5%
stock +14% · XLV +22%
matured Aug 1, 26
Raymond James ↗
Jul 31, 25
▲ Strong Buy · 🎯$102
Price at call : $79.28 — upside +29%
Today : $85.06 — upside +20%
Expected +29% · Actual +10% · Reason (≥ +15%) : ✗ No
🎯 on DXCM : 42% (12 calls matureds) · 📊 on Health : 46.4% · +1.6% (403 calls)
+10.1%
stock +10% · XLV +24%
matured Jul 31, 26
Canaccord Genuity ↗
May 2, 25
▲ Buy · 🎯$106
Price at call : $80.27 — upside +32%
Today : $85.06 — upside +25%
Expected +32% · Actual -25% · Reason (≥ +15%) : ✗ No
🎯 on DXCM : 42% (12 calls matureds) · 📊 on Health : 52.6% · +5.0% (154 calls)
-25.2%
stock -25% · XLV +5%
matured May 2, 26
Canaccord Genuity ↗
Feb 14, 25
▲ Buy · 🎯$103
Price at call : $89.07 — upside +16%
Today : $85.06 — upside +21%
Expected +16% · Actual -21% · Reason (≥ +15%) : ✗ No
🎯 on DXCM : 42% (12 calls matureds) · 📊 on Health : 52.6% · +5.0% (154 calls)
-20.9%
stock -21% · XLV +9%
matured Feb 14, 26
Canaccord Genuity ↗
Dec 9, 24
▲ Buy · 🎯$99
Price at call : $79.41 — upside +25%
Today : $85.06 — upside +16%
Expected +25% · Actual -15% · Reason (≥ +15%) : ✗ No
🎯 on DXCM : 42% (12 calls matureds) · 📊 on Health : 52.6% · +5.0% (154 calls)
-14.9%
stock -15% · XLV +6%
matured Dec 9, 25
Raymond James ↗
Oct 25, 24
▲ Strong Buy · 🎯$99
Price at call : $72.1 — upside +37%
Today : $85.06 — upside +16%
Expected +37% · Actual -2% · Reason (≥ +15%) : ✗ No
🎯 on DXCM : 42% (12 calls matureds) · 📊 on Health : 46.4% · +1.6% (403 calls)
-2.0%
stock -2% · XLV -2%
matured Oct 25, 25
▲ Buy · 🎯$120
Price at call : $67.48 — upside +78%
Today : $85.06 — upside +41%
Expected +78% · Actual +33% · Reason (≥ +15%) : ✓ Yes
🎯 on DXCM : 67% (9 calls matureds) · 📊 on Health : 51.2% · +5.3% (123 calls)
+32.7%
stock +33% · XLV -10%
matured Jul 26, 25
Canaccord Genuity ↗
Jul 26, 24
▲ Buy · 🎯$89
Price at call : $64 — upside +39%
Today : $85.06 — upside +5%
Expected +39% · Actual +40% · Reason (≥ +15%) : ✓ Yes
🎯 on DXCM : 42% (12 calls matureds) · 📊 on Health : 52.6% · +5.0% (154 calls)
+39.9%
stock +40% · XLV -10%
matured Jul 26, 25
Canaccord Genuity ↗
Jul 23, 24
▲ Buy · 🎯$145
Price at call : $112.13 — upside +29%
Today : $85.06 — upside +70%
Expected +29% · Actual -23% · Reason (≥ +15%) : ✗ No
🎯 on DXCM : 42% (12 calls matureds) · 📊 on Health : 52.6% · +5.0% (154 calls)
-22.9%
stock -23% · XLV -8%
matured Jul 23, 25
Raymond James ↗
Apr 26, 24
▲ Strong Buy · 🎯$160
Price at call : $125.81 — upside +27%
Today : $85.06 — upside +88%
Expected +27% · Actual -43% · Reason (≥ +15%) : ✗ No
🎯 on DXCM : 42% (12 calls matureds) · 📊 on Health : 46.4% · +1.6% (403 calls)
-43.4%
stock -43% · XLV -1%
matured Apr 26, 25
Canaccord Genuity ↗
Apr 26, 24
▲ Buy · 🎯$145
Price at call : $124.34 — upside +17%
Today : $85.06 — upside +70%
Expected +17% · Actual -43% · Reason (≥ +15%) : ✗ No
🎯 on DXCM : 42% (12 calls matureds) · 📊 on Health : 52.6% · +5.0% (154 calls)
-42.8%
stock -43% · XLV -1%
matured Apr 26, 25
Raymond James ↗
Jan 23, 24
▲ Strong Buy · 🎯$151
Price at call : $127.12 — upside +19%
Today : $85.06 — upside +78%
Expected +19% · Actual -31% · Reason (≥ +15%) : ✗ No
🎯 on DXCM : 42% (12 calls matureds) · 📊 on Health : 46.4% · +1.6% (403 calls)
-31.5%
stock -31% · XLV +2%
matured Jan 22, 25
Raymond James ↗
Jan 3, 24
▲ Strong Buy · 🎯$147
Price at call : $121.83 — upside +21%
Today : $85.06 — upside +73%
Expected +21% · Actual -33% · Reason (≥ +15%) : ✗ No
🎯 on DXCM : 42% (12 calls matureds) · 📊 on Health : 46.4% · +1.6% (403 calls)
-33.5%
stock -33% · XLV -0%
matured Jan 2, 25
Raymond James ↗
Sep 15, 23
▲ Strong Buy · 🎯$131
Price at call : $96.35 — upside +36%
Today : $85.06 — upside +54%
Expected +36% · Actual -27% · Reason (≥ +15%) : ✗ No
🎯 on DXCM : 42% (12 calls matureds) · 📊 on Health : 46.4% · +1.6% (403 calls)
-27.3%
stock -27% · XLV +19%
matured Sep 14, 24
Canaccord Genuity ↗
Jul 28, 23
▲ Buy · 🎯$150
Price at call : $124.56 — upside +20%
Today : $85.06 — upside +76%
Expected +20% · Actual -46% · Reason (≥ +15%) : ✗ No
🎯 on DXCM : 42% (12 calls matureds) · 📊 on Health : 52.6% · +5.0% (154 calls)
-45.8%
stock -46% · XLV +12%
matured Jul 27, 24
Raymond James ↗
Jul 28, 23
▲ Strong Buy · 🎯$154
Price at call : $132.38 — upside +16%
Today : $85.06 — upside +81%
Expected +16% · Actual -49% · Reason (≥ +15%) : ✗ No
🎯 on DXCM : 42% (12 calls matureds) · 📊 on Health : 46.4% · +1.6% (403 calls)
-49.0%
stock -49% · XLV +11%
matured Jul 27, 24
▲ Buy · 🎯$150
Price at call : $123.5 — upside +21%
Today : $85.06 — upside +76%
Expected +21% · Actual -8% · Reason (≥ +15%) : ✗ No
🎯 on DXCM : 67% (9 calls matureds) · 📊 on Health : 51.2% · +5.3% (123 calls)
-8.1%
stock -8% · XLV +12%
matured Jun 25, 24
▲ Buy · 🎯$134
Price at call : $118.44 — upside +13%
Today : $85.06 — upside +58%
Expected +13% · Actual +6% · Reason (≥ +15%) : ✗ No
🎯 on DXCM : 67% (9 calls matureds) · 📊 on Health : 51.2% · +5.3% (123 calls)
+6.2%
stock +6% · XLV +5%
matured Apr 27, 24
Canaccord Genuity ↗
Apr 28, 23
▲ Buy · 🎯$135
Price at call : $121.34 — upside +11%
Today : $85.06 — upside +59%
Expected +11% · Actual +4% · Reason (≥ +15%) : ✗ No
🎯 on DXCM : 42% (12 calls matureds) · 📊 on Health : 52.6% · +5.0% (154 calls)
+3.7%
stock +4% · XLV +5%
matured Apr 27, 24
Raymond James ↗
Apr 28, 23
▲ Strong Buy · 🎯$140
Price at call : $121.34 — upside +15%
Today : $85.06 — upside +65%
Expected +15% · Actual +4% · Reason (≥ +15%) : ✗ No
🎯 on DXCM : 42% (12 calls matureds) · 📊 on Health : 46.4% · +1.6% (403 calls)
+3.7%
stock +4% · XLV +5%
matured Apr 27, 24
▲ Buy · 🎯$132
Price at call : $118.93 — upside +11%
Today : $85.06 — upside +55%
Expected +11% · Actual +13% · Reason (≥ +15%) : ✗ No
🎯 on DXCM : 67% (9 calls matureds) · 📊 on Health : 51.2% · +5.3% (123 calls)
+12.6%
stock +13% · XLV +4%
matured Apr 16, 24
Raymond James ↗
Apr 17, 23
▲ Strong Buy · 🎯$138
Price at call : $118.65 — upside +16%
Today : $85.06 — upside +62%
Expected +16% · Actual +15% · Reason (≥ +15%) : ✓ Yes
🎯 on DXCM : 42% (12 calls matureds) · 📊 on Health : 46.4% · +1.6% (403 calls)
+15.1%
stock +15% · XLV +3%
matured Apr 16, 24
Raymond James ↗
Oct 28, 22
▲ Outperform · 🎯$125
Price at call : $120.87 — upside +3%
Today : $85.06 — upside +47%
Expected +3% · Actual -30% · Reason (≥ +15%) : ✗ No
🎯 on DXCM : 42% (12 calls matureds) · 📊 on Health : 46.4% · +1.6% (403 calls)
-29.8%
stock -30% · XLV -7%
matured Oct 28, 23
▲ Buy · 🎯$110
Price at call : $100.22 — upside +10%
Today : $85.06 — upside +29%
Expected +10% · Actual -15% · Reason (≥ +15%) : ✗ No
🎯 on DXCM : 67% (9 calls matureds) · 📊 on Health : 51.2% · +5.3% (123 calls)
-15.0%
stock -15% · XLV +8%
matured Oct 10, 23
Raymond James ↗
Aug 1, 22
▲ Outperform · 🎯$101
Price at call : $83.83 — upside +20%
Today : $85.06 — upside +19%
Expected +20% · Actual +46% · Reason (≥ +15%) : ✓ Yes
🎯 on DXCM : 42% (12 calls matureds) · 📊 on Health : 46.4% · +1.6% (403 calls)
+45.5%
stock +46% · XLV +2%
matured Aug 1, 23
▲ Buy · 🎯$105
Price at call : $76.6 — upside +37%
Today : $85.06 — upside +23%
Expected +37% · Actual +63% · Reason (≥ +15%) : ✓ Yes
🎯 on DXCM : 67% (9 calls matureds) · 📊 on Health : 51.2% · +5.3% (123 calls)
+62.7%
stock +63% · XLV +1%
matured Jun 24, 23
Raymond James ↗
Apr 29, 22
▲ Outperform · 🎯$121.5
Price at call : $102.14 — upside +19%
Today : $85.06 — upside +43%
Expected +19% · Actual +16% · Reason (≥ +15%) : ✓ Yes
🎯 on DXCM : 42% (12 calls matureds) · 📊 on Health : 46.4% · +1.6% (403 calls)
+16.0%
stock +16% · XLV +3%
matured Apr 29, 23
▲ Buy · 🎯$133.75
Price at call : $105.09 — upside +27%
Today : $85.06 — upside +57%
Expected +27% · Actual +2% · Reason (≥ +15%) : ✗ No
🎯 on DXCM : 67% (9 calls matureds) · 📊 on Health : 51.2% · +5.3% (123 calls)
+1.6%
stock +2% · XLV -0%
matured Feb 3, 23
Canaccord Genuity ↗
Jul 30, 21
▲ Buy · 🎯$125
Price at call : $127.84 — upside -2%
Today : $85.06 — upside +47%
Expected -2% · Actual -34% · Reason (≥ +15%) : ✗ No
🎯 on DXCM : 42% (12 calls matureds) · 📊 on Health : 52.6% · +5.0% (154 calls)
-34.4%
stock -34% · XLV -1%
matured Jul 30, 22
Canaccord Genuity ↗
Apr 30, 21
▲ Buy · 🎯$113.75
Price at call : $96.53 — upside +18%
Today : $85.06 — upside +34%
Expected +18% · Actual +5% · Reason (≥ +15%) : ✗ No
🎯 on DXCM : 42% (12 calls matureds) · 📊 on Health : 52.6% · +5.0% (154 calls)
+5.5%
stock +5% · XLV +7%
matured Apr 30, 22
▲ Buy
Actual -43% · Reason (≥ +15%) : ✗ No
🎯 on DXCM : 67% (9 calls matureds) · 📊 on Health : 51.2% · +5.3% (123 calls)
-42.5%
stock -43% · XLV +20%
matured Oct 31, 17
Frequently asked questions
Should I buy Dexcom stock?
This isn't buy advice. For Dexcom, the analyst consensus is "Buy", with an average price target of $95.00 (+12% vs the current price). What matters is their past reliability on this stock: the most reliable one is right 100% of the time (3 calls tracked on Dexcom). We show the numbers — you decide.
Is it too late to buy Dexcom? How high can it go?
The most bullish analyst target on Dexcom is $115 (+35% above today's price); the average is $95.00. That's the upside they see. Check how reliable those analysts have actually been on Dexcom on our site before trusting it.
Is Dexcom still a good buy?
The most useful "opinion" isn't an opinion — it's a track record: 29 analysts have a real record on Dexcom, the best hitting 100% over 3 calls. Current consensus: "Buy". Make your call on data, not noise.
Should you invest in Dexcom? The case for and against
The arguments for and against, one by one, from the numbers: why invest in DXCM (and why hesitate).
What has Dexcom's past performance been?
Historical returns and a "how much if I had invested" calculator: DXCM performance & returns.
What is the best month to buy DXCM?
The 12 months ranked by the stock's past returns: best & worst month to buy DXCM.
BIIB 
VRTX 
REGN 
UNH 
EW 
SRPT 
VEEV 
BSX